[Form 4] Paysign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Paysign, Inc. (PAYS) Form 4 highlights insider activity by CFO Jeffery B. Baker.

• On 07/31/2025 Baker received 64,000 common shares as part of a previously granted restricted stock award; the grant vests 20 % annually from 07/31/2022 through 07/31/2027 and carried a $0 exercise price.
• On 08/04/2025 he sold 30,396 shares at a weighted-average price of $7.0851 (sales occurred within a price range of $6.9976–$7.1530).

Following these transactions Baker directly owns 252,273 common shares and retains derivative rights to 128,000 additional shares tied to the same award. The filing discloses no new option grants, compensation changes or company-specific events and indicates the sale was executed under a Rule 10b5-1 plan. Overall, the activity appears routine, with the executive maintaining a substantial equity stake.

Positive

• CFO retains 252,273 shares post-sale, indicating continued alignment with shareholders.

Negative

• Insider sold 30,396 shares, which some investors may interpret as reduced short-term confidence.

Insights

Securities Analyst

TL;DR: Routine vesting plus modest sale; neutral insider signal.

The CFO converted 64 k restricted shares and monetised ~47 % of that lot at $7.09. Proceeds are modest and he still controls 252 k shares, preserving meaningful alignment with shareholders. No new awards, no unusual timing, and the trade is flagged as 10b5-1, limiting information-content. Market impact should be minimal unless compounded by other data points.

Corporate Governance Specialist

TL;DR: Governance-clean filing; share sale small vs. holdings.

Because the transaction occurs under a pre-arranged trading plan and within scheduled vesting, the sale raises no governance red flags. Baker’s remaining direct plus derivative holdings (≈380 k shares) continue to link compensation with performance. The pattern is consistent with diversification rather than signalling negative outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baker Jeffery Bradford

(Last) (First) (Middle)

2615 ST. ROSE PKWY

(Street)

HENDERSON NV 89052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Paysign, Inc. [ PAYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2025		M		64,000(1)	A	$0	282,669	D
Common Stock	08/04/2025		S(2)		30,396	D	$7.0851(2)	252,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Grant	(1)	07/31/2025		M			64,000	(1)	07/31/2027	Common stock	64,000	$0.00	128,000	D

Explanation of Responses:

1. One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	s/s/ Jeffrey B. Baker	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Paysign (PAYS) shares did the CFO acquire on 31 July 2025?

64,000 shares were acquired through restricted stock vesting.

At what average price did Jeffery Baker sell Paysign stock on 4 Aug 2025?

He sold at a weighted-average price of $7.0851 per share.

What is the CFO's Paysign shareholding after the reported transactions?

Baker directly owns 252,273 common shares and holds derivative rights to 128,000 additional shares.

When will the restricted stock grant be fully vested?

The grant vests 20 % annually and will be fully vested on 31 July 2027.

Was the sale executed under a Rule 10b5-1 plan?

Yes. The filing checks the 10b5-1 box, indicating the trade was made under a pre-arranged plan.